newsfilter
← Latest News
Business Wire·

Cybin to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference

Cybin Inc. (NYSE:CYBN) (Cboe CA:CYBN) ("Cybin" or the "Company"), a breakthrough Phase 3 clinical stage neuropsychiatry company committed to revolutionizing mental healthcare through proprietary drug discovery platforms